BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33654013)

  • 21. Outpatient oral anticancer agent utilization and costs in Manitoba from 2003 to 2016: a population-based study.
    Leong C; Czaykowski P; Geirnaert M; Katz A; Dragan R; Yogendran M; Raymond C
    Can J Public Health; 2021 Jun; 112(3):530-540. PubMed ID: 33471346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Satisfaction With an Interactive Voice Response System and Symptom Management Toolkit Intervention to Improve Adherence in Patients Prescribed an Oral Anticancer Agent.
    Marshall VK; Given BA
    Oncol Nurs Forum; 2020 Nov; 47(6):637-648. PubMed ID: 33063783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Medicaid spending in schizoaffective patients treated with once monthly paliperidone palmitate or oral atypical antipsychotics.
    Xiao Y; Muser E; Fu DJ; Lafeuille MH; Pilon D; Emond B; Wu A; Duh MS; Lefebvre P
    Curr Med Res Opin; 2016; 32(4):759-69. PubMed ID: 26750639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States.
    Wilson LE; Spees L; Pritchard J; Greiner MA; Scales CD; Baggett CD; Kaye D; George DJ; Zhang T; Wheeler SB; Dinan MA
    Kidney Cancer; 2021; 5(3):115-127. PubMed ID: 34632169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-management Needs of Breast Cancer Survivors After Treatment: Results From a Focus Group Interview.
    Kim SH; Park S; Kim SJ; Hur MH; Lee BG; Han MS
    Cancer Nurs; 2020; 43(1):78-85. PubMed ID: 30148729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Side Effects, Self-Management Activities, and Adherence to Oral Anticancer Agents.
    Jiang Y; Wickersham KE; Zhang X; Barton DL; Farris KB; Krauss JC; Harris MR
    Patient Prefer Adherence; 2019; 13():2243-2252. PubMed ID: 32099335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication Adherence Among Adults With Comorbid Chronic Conditions Initiating Oral Anticancer Agent Therapy for Multiple Myeloma.
    Gatwood J; Dashputre A; Rajpurohit A; Gatwood K; Mackler E; Wallace L; Farris K; Rizvi-Toner A; Farley J
    JCO Oncol Pract; 2022 Sep; 18(9):e1475-e1483. PubMed ID: 35700416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
    Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
    Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delineating the concept of self-management in chronic conditions: a concept analysis.
    Van de Velde D; De Zutter F; Satink T; Costa U; Janquart S; Senn D; De Vriendt P
    BMJ Open; 2019 Jul; 9(7):e027775. PubMed ID: 31315862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The patient-provider discordance in patients' needs assessment: a qualitative study in breast cancer patients receiving oral chemotherapy.
    Wei C; Nengliang Y; Yan W; Qiong F; Yuan C
    J Clin Nurs; 2017 Jan; 26(1-2):125-132. PubMed ID: 27647758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collaborative network to take responsibility for oral anticancer therapy (CONTACT): Study-protocol investigating the impact of a care pathway.
    Kinnaer LM; Decoene E; Van Hecke A; Foulon V
    J Adv Nurs; 2019 Dec; 75(12):3726-3739. PubMed ID: 31310353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helping patients help themselves: A systematic review of self-management support strategies in primary health care practice.
    Dineen-Griffin S; Garcia-Cardenas V; Williams K; Benrimoj SI
    PLoS One; 2019; 14(8):e0220116. PubMed ID: 31369582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Self-management Knowledge and Support on the Relationships Among Self-efficacy, Patient Activation, and Self-management in Rural Patients With Heart Failure.
    Young L; Kupzyk K; Barnason S
    J Cardiovasc Nurs; 2017; 32(4):E1-E8. PubMed ID: 28060085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of treatment patterns, healthcare resource utilization, and costs among young adult Medicaid beneficiaries with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics in the US.
    Manjelievskaia J; Amos TB; El Khoury AC; Vlahiotis A; Cole A; Juneau P
    J Med Econ; 2018 Dec; 21(12):1221-1229. PubMed ID: 30238806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists.
    Timmers L; Boons CC; Verbrugghe M; van den Bemt BJ; Van Hecke A; Hugtenburg JG
    BMC Cancer; 2017 Feb; 17(1):122. PubMed ID: 28187759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-management, self-management support needs and interventions in advanced cancer: a scoping review.
    Budhwani S; Wodchis WP; Zimmermann C; Moineddin R; Howell D
    BMJ Support Palliat Care; 2019 Mar; 9(1):12-25. PubMed ID: 30121581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deciphering programs for optimal self-management of persistent musculoskeletal-related pain and disability - Clinical implications for PTs.
    Longtin C; Coutu MF; Tousignant-Laflamme Y
    Physiother Theory Pract; 2021 Dec; 37(12):1264-1272. PubMed ID: 31793371
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.